A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma

Pathol Int. 2012 Apr;62(4):226-31. doi: 10.1111/j.1440-1827.2011.02778.x. Epub 2012 Jan 30.

Abstract

An evaluation of epidermal growth factor receptor (EGFR) phenotypic expression in malignant pleural and peritoneal mesothelioma was undertaken, using immunohistochemical (IHC) and fluorescence in situ hybridization (FISH) analysis. Thirty-eight malignant mesothelioma (MM) specimens were subjected to IHC staining and FISH to evaluate the expression of EGFR protein and gene status. Overall positive IHC reaction was detected in 20/38 (53%) cases, in 11/22 (50%) pleural MM, and in 9/16 (56%) peritoneal MM. Our study confirmed that EGFR membranous expression is a common feature in MM, but not in benign mesothelial lesion. Thirty-seven cases did not show a gene copy number gain. Only one case showed a copy number gain. The protein overexpression of EGFR was not related to a gene copy number gain.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / metabolism*
  • DNA, Neoplasm / analysis
  • ErbB Receptors / genetics
  • ErbB Receptors / metabolism*
  • Female
  • Gene Dosage
  • Gene Expression Regulation, Neoplastic
  • Genetic Markers
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Mesothelioma / genetics
  • Mesothelioma / metabolism*
  • Mesothelioma / pathology
  • Middle Aged
  • Peritoneal Neoplasms / genetics
  • Peritoneal Neoplasms / metabolism*
  • Peritoneal Neoplasms / pathology
  • Pleural Neoplasms / genetics
  • Pleural Neoplasms / metabolism*
  • Pleural Neoplasms / pathology

Substances

  • Biomarkers, Tumor
  • DNA, Neoplasm
  • Genetic Markers
  • ErbB Receptors